America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.
Stock data | 2023 | Change |
---|---|---|
Price | $0.0028 | N/A |
Market Cap | $59.06M | N/A |
Shares Outstanding | 21.09B | 0.02% |
Employees | 7.00 | N/A |
Shareholder Equity | -4.53M | 17.24% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -77.78 | N/A |
P/S Ratio | 289.08 | N/A |
P/B Ratio | -13.05 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.1718 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $204.31K | N/A |
Earnings | -$777.34K | N/A |
EPS | 0 | N/A |
Earnings Yield | -0.0129 | N/A |
Gross Margin | 0.8252 | N/A |
Operating Margin | -2.41 | N/A |
Net income margin | -3.80 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $299.13K | N/A |
Total Debt | $1.87M | N/A |
Cash on Hand | $54.15K | N/A |
Debt to Equity | -1.0661 | -1.93% |
Cash to Debt | 0.0290 | -39.46% |
Current Ratio | 0.0580 | -18.59% |